Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 13 of 18
Newsletters
The CEO’s Job Is Tougher Than Ever
By
Aaron Pressman
and
Adam Lashinsky
November 18, 2019
Finance
What the Sackler Offer and the J&J Opioid Verdict Tell Us About the Next Big Test for Drugmakers—an Ohio Trial in October
By
Ellen Florian
August 27, 2019
Health
J&J Shares Rise After Lower Than Expected Award for Company’s Part in Opioid Crisis
By
Jef Feeley
,
Riley Griffin
and
Bloomberg
August 27, 2019
Johnson & Johnson Accused of Dodging Liability for Its Alleged Role in Opioid Epidemic
By
Jef Feeley
and
Bloomberg
July 15, 2019
Health
Johnson & Johnson to Test a Pioneering HIV Vaccine: Brainstorm Health
By
Sy Mukherjee
July 12, 2019
Leadership
J&J CEO’s West Point Lesson: Great Leaders Know How to Listen
By
Susie Gharib
April 17, 2019
Xarelto to Become First Prescription Drug With TV Ads That Includes Pricing
By
Erik Sherman
March 29, 2019
Jury Awards $29 Million in Latest Johnson & Johnson Cancer-Causing Baby Powder Lawsuit
By
Brittany Shoot
March 15, 2019
Finance
Mithril Capital’s Ajay Royan Talks About Working with Peter Thiel and Why ‘Investing Is Hard’
By
Rey Mashayekhi
February 28, 2019
Johnson & Johnson Will Be The First Drug Company To Put Prescription Medication Prices in TV Ads
By
Laura Stampler
February 8, 2019
Johnson & Johnson’s Slowdown Signals a Warning to Health Care Sector
By
Bloomberg
January 22, 2019
Health
Johnson & Johnson’s $50 Billion Baby Powder Problem Just Got a Whole Lot Worse. Here’s Why
By
Lucas Laursen
December 19, 2018
Glaxo to Split in Two Following Venture Deal with Pfizer
By
Bloomberg
December 19, 2018
Leadership
Companies Strike Back, Moonves Fired, China: CEO Daily for December 18, 2018
By
Lucas Laursen
and
Alan Murray
December 18, 2018
Health
Johnson & Johnson Knew Baby Powder Contained Asbestos for Decades, Report Claims
By
Chris Morris
December 14, 2018
Most Popular
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By
Nino Paoli
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in...
By
Nino Paoli
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House...
By
Jason Ma